{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T22:39:25Z","timestamp":1788043165586,"version":"build-2784847793"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03799-x","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T15:39:56Z","timestamp":1745249996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ganoderic acid a potentiates cisplatin\u2019s cytotoxicity on gallbladder cancer cells by promoting DNA damage and inhibiting cell stemness"],"prefix":"10.1186","volume":"23","author":[{"given":"Gan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoming","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfeng","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"issue":"1","key":"3799_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","volume":"8","author":"JC Roa","year":"2022","unstructured":"Roa JC, Garc\u00eda P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer. Nat Rev Dis Primers. 2022;8(1):69.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"3799_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41571-022-00672-8","volume":"19","author":"T Ugai","year":"2022","unstructured":"Ugai T, Sasamoto N, Lee HY, Ando M, Song M, Tamimi RM, et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol. 2022;19(10):656\u201373.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"3799_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12916-021-01922-9","volume":"19","author":"K Papier","year":"2021","unstructured":"Papier K, Fensom GK, Knuppel A, Appleby PN, Tong TYN, Schmidt JA, et al. Meat consumption and risk of 25 common conditions: outcome-wide analyses in 475,000 men and women in the UK biobank study. BMC Med. 2021;19(1):53.","journal-title":"BMC Med"},{"issue":"2","key":"3799_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/aje\/kwaa199","volume":"190","author":"J Koshiol","year":"2021","unstructured":"Koshiol J, Van De Wyngard V, McGee EE, Cook P, Pfeiffer RM, Mardones N, et al. The Chile biliary longitudinal study: A gallstone cohort. Am J Epidemiol. 2021;190(2):196\u2013206.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"3799_CR5","doi-asserted-by":"publisher","first-page":"e462","DOI":"10.1002\/ctm2.462","volume":"11","author":"P Chen","year":"2021","unstructured":"Chen P, Wang Y, Li J, Bo X, Wang J, Nan L, et al. Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single-cell RNA sequencing. Clin Transl Med. 2021;11(6):e462.","journal-title":"Clin Transl Med"},{"key":"3799_CR6","doi-asserted-by":"publisher","first-page":"101693","DOI":"10.1016\/j.suronc.2021.101693","volume":"40","author":"MK Sung","year":"2022","unstructured":"Sung MK, Lee W, Lee JH, Song KB, Kim SC, Kwak BJ, et al. Comparing survival rate and appropriate surgery methods according to tumor location in T2 gallbladder cancer. Surg Oncol. 2022;40:101693.","journal-title":"Surg Oncol"},{"issue":"16","key":"3799_CR7","doi-asserted-by":"publisher","first-page":"e2308531","DOI":"10.1002\/advs.202308531","volume":"11","author":"S Xu","year":"2024","unstructured":"Xu S, Yuan Z, Jiang C, Chen W, Li Q, Chen T. DNMT3A cooperates with YAP\/TAZ to drive gallbladder cancer metastasis. Adv Sci (Weinh). 2024;11(16):e2308531.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"3799_CR8","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/iju.15586","volume":"31","author":"G Palermo","year":"2024","unstructured":"Palermo G, Bizzarri FP, Scarciglia E, Sacco E, Moosavi Seyed K, Russo P, et al. The mental and emotional status after radical cystectomy and different urinary diversion orthotopic bladder substitution versus external urinary diversion after radical cystectomy: A propensity score-matched study. Int J Urol. 2024;31(12):1423\u20138.","journal-title":"Int J Urol"},{"issue":"6","key":"3799_CR9","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1001\/jamaoncol.2019.0270","volume":"5","author":"RT Shroff","year":"2019","unstructured":"Shroff RT, Javle MM, Xiao L, Kaseb AO, Varadhachary GR, Wolff RA, et al. Gemcitabine, cisplatin, and nab-Paclitaxel for the treatment of advanced biliary tract cancers: A phase 2 clinical trial. JAMA Oncol. 2019;5(6):824\u201330.","journal-title":"JAMA Oncol"},{"key":"3799_CR10","doi-asserted-by":"crossref","unstructured":"Sturm N, Schuhbaur JS, H\u00fcttner F, Perkhofer L, Ettrich TJ. Gallbladder cancer: current multimodality treatment concepts and future directions. Cancers (Basel). 2022;14(22).","DOI":"10.3390\/cancers14225580"},{"issue":"10391","key":"3799_CR11","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","volume":"401","author":"RK Kelley","year":"2023","unstructured":"Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;401(10391):1853\u201365.","journal-title":"Lancet"},{"key":"3799_CR12","doi-asserted-by":"publisher","first-page":"113564","DOI":"10.1016\/j.ejca.2024.113564","volume":"199","author":"BH Ten Haaft","year":"2024","unstructured":"Ten Haaft BH, Pedregal M, Prato J, Kl\u00fcmpen HJ, Moreno V, Lamarca A. Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: current advancements and future perspectives. Eur J Cancer. 2024;199:113564.","journal-title":"Eur J Cancer"},{"key":"3799_CR13","doi-asserted-by":"publisher","first-page":"100938","DOI":"10.1016\/j.drup.2023.100938","volume":"68","author":"F Li","year":"2023","unstructured":"Li F, Zheng Z, Chen W, Li D, Zhang H, Zhu Y, et al. Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms. Drug Resist Updat. 2023;68:100938.","journal-title":"Drug Resist Updat"},{"key":"3799_CR14","doi-asserted-by":"publisher","first-page":"101059","DOI":"10.1016\/j.drup.2024.101059","volume":"73","author":"F Li","year":"2024","unstructured":"Li F, Zhang H, Huang Y, Li D, Zheng Z, Xie K, et al. Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist Updat. 2024;73:101059.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"3799_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12885-018-5211-y","volume":"19","author":"MS You","year":"2019","unstructured":"You MS, Ryu JK, Choi YH, Choi JH, Huh G, Paik WH, et al. Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin. BMC Cancer. 2019;19(1):10.","journal-title":"BMC Cancer"},{"issue":"8","key":"3799_CR16","doi-asserted-by":"publisher","first-page":"10553","DOI":"10.1007\/s13277-016-4957-6","volume":"37","author":"M Zhan","year":"2016","unstructured":"Zhan M, Zhao X, Wang H, Chen W, Xu S, Wang W, et al. miR-145 sensitizes gallbladder cancer to cisplatin by regulating multidrug resistance associated protein 1. Tumour Biol. 2016;37(8):10553\u201362.","journal-title":"Tumour Biol"},{"issue":"1","key":"3799_CR17","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s13023-021-01955-6","volume":"16","author":"G Zhu","year":"2021","unstructured":"Zhu G, Wei A, Wang B, Yang J, Yan Y, Wang K, et al. Haploidentical Haematopoietic stem cell transplantation for malignant infantile osteopetrosis and intermediate osteopetrosis: a retrospective analysis of a single centre. Orphanet J Rare Dis. 2021;16(1):314.","journal-title":"Orphanet J Rare Dis"},{"key":"3799_CR18","doi-asserted-by":"publisher","first-page":"114561","DOI":"10.1016\/j.bcp.2021.114561","volume":"188","author":"H Bao","year":"2021","unstructured":"Bao H, Li H, Jia Y, Xiao Y, Luo S, Zhang D, et al. Ganoderic acid A exerted antidepressant-like action through FXR modulated NLRP3 inflammasome and synaptic activity. Biochem Pharmacol. 2021;188:114561.","journal-title":"Biochem Pharmacol"},{"key":"3799_CR19","doi-asserted-by":"publisher","first-page":"109529","DOI":"10.1016\/j.cbi.2021.109529","volume":"344","author":"JQ Ma","year":"2021","unstructured":"Ma JQ, Zhang YJ, Tian ZK. Anti-oxidant, anti-inflammatory and anti-fibrosis effects of Ganoderic acid A on carbon tetrachloride induced nephrotoxicity by regulating the Trx\/TrxR and JAK\/ROCK pathway. Chem Biol Interact. 2021;344:109529.","journal-title":"Chem Biol Interact"},{"issue":"9","key":"3799_CR20","doi-asserted-by":"publisher","first-page":"e13686","DOI":"10.1111\/acel.13686","volume":"21","author":"H Yuan","year":"2022","unstructured":"Yuan H, Xu Y, Luo Y, Zhang JR, Zhu XX, Xiao JH. Ganoderic acid D prevents oxidative stress-induced senescence by targeting 14-3-3\u03b5 to activate CaM\/CaMKII\/NRF2 signaling pathway in mesenchymal stem cells. Aging Cell. 2022;21(9):e13686.","journal-title":"Aging Cell"},{"key":"3799_CR21","doi-asserted-by":"publisher","first-page":"116367","DOI":"10.1016\/j.ejmech.2024.116367","volume":"270","author":"Y Li","year":"2024","unstructured":"Li Y, Li G, Zuo C, Wang X, Han F, Jia Y, et al. Discovery of Ganoderic acid A (GAA) protacs as MDM2 protein degraders for the treatment of breast cancer. Eur J Med Chem. 2024;270:116367.","journal-title":"Eur J Med Chem"},{"issue":"16","key":"3799_CR22","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1055\/s-0032-1315303","volume":"78","author":"X Yao","year":"2012","unstructured":"Yao X, Li G, Xu H, L\u00fc C. Inhibition of the JAK-STAT3 signaling pathway by Ganoderic acid A enhances chemosensitivity of HepG2 cells to cisplatin. Planta Med. 2012;78(16):1740\u20138.","journal-title":"Planta Med"},{"issue":"4","key":"3799_CR23","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.3892\/mmr.2017.7048","volume":"16","author":"X Wang","year":"2017","unstructured":"Wang X, Sun D, Tai J, Wang L. Ganoderic acid A inhibits proliferation and invasion, and promotes apoptosis in human hepatocellular carcinoma cells. Mol Med Rep. 2017;16(4):3894\u2013900.","journal-title":"Mol Med Rep"},{"key":"3799_CR24","doi-asserted-by":"publisher","first-page":"155675","DOI":"10.1016\/j.phymed.2024.155675","volume":"129","author":"B Luo","year":"2024","unstructured":"Luo B, Song L, Chen L, Cai Y, Zhang M, Wang S. Ganoderic acid D attenuates gemcitabine resistance of triple-negative breast cancer cells by inhibiting Glycolysis via HIF-1alpha destabilization. Phytomedicine. 2024;129:155675.","journal-title":"Phytomedicine"},{"key":"3799_CR25","doi-asserted-by":"publisher","first-page":"149102","DOI":"10.1016\/j.brainres.2024.149102","volume":"1842","author":"X Ding","year":"2024","unstructured":"Ding X, Liu F, Wang H, Wang Y, Li G, Zhang X, et al. Ganoderic acid a decreased A\u03b242-induced neurotoxicity in PC12 cells by reduced mitochondrial damage. Brain Res. 2024;1842:149102.","journal-title":"Brain Res"},{"key":"3799_CR26","doi-asserted-by":"publisher","first-page":"155675","DOI":"10.1016\/j.phymed.2024.155675","volume":"129","author":"B Luo","year":"2024","unstructured":"Luo B, Song L, Chen L, Cai Y, Zhang M, Wang S. Ganoderic acid D attenuates gemcitabine resistance of triple-negative breast cancer cells by inhibiting Glycolysis via HIF-1\u03b1 destabilization. Phytomedicine. 2024;129:155675.","journal-title":"Phytomedicine"},{"issue":"1","key":"3799_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10616-017-0160-x","volume":"70","author":"T Bi","year":"2018","unstructured":"Bi T, Zhu A, Yang X, Qiao H, Tang J, Liu Y, et al. Metformin synergistically enhances antitumor activity of cisplatin in gallbladder cancer via the PI3K\/AKT\/ERK pathway. Cytotechnology. 2018;70(1):439\u201348.","journal-title":"Cytotechnology"},{"issue":"4","key":"3799_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/jpp\/rgad116","volume":"76","author":"E Gong","year":"2024","unstructured":"Gong E, Pan J, Ye Z, Cai X, Zheng H, Yin Z, et al. Ganoderic acid A suppresses autophagy by regulating the circFLNA\/miR-486-3p\/CYP1A1\/XRCC1 axis to strengthen the sensitivity of lung cancer cells to cisplatin. J Pharm Pharmacol. 2024;76(4):354\u201367.","journal-title":"J Pharm Pharmacol"},{"key":"3799_CR29","doi-asserted-by":"crossref","unstructured":"Meng Y, Ning Q, Liu Y, Pang Y, Ren H, Yang T et al. Ganoderic acid A suppresses the phenotypic modulation of pulmonary artery smooth muscle cells through the inactivation of PI3K\/Akt pathway in pulmonary arterial hypertension. 2021;42:e83221.","DOI":"10.1590\/fst.83221"},{"issue":"5","key":"3799_CR30","first-page":"577","volume":"21","author":"J Jiang","year":"2008","unstructured":"Jiang J, Grieb B, Thyagarajan A, Sliva D. Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling. Int J Mol Med. 2008;21(5):577\u201384.","journal-title":"Int J Mol Med"},{"key":"3799_CR31","doi-asserted-by":"crossref","unstructured":"Aly HAA. Mitochondria-Mediated apoptosis induced testicular dysfunction in diabetic rats: ameliorative effect of Resveratrol. Endocrinology. 2021;162(4).","DOI":"10.1210\/endocr\/bqab018"},{"issue":"2","key":"3799_CR32","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s13277-015-3929-6","volume":"37","author":"A Yadav","year":"2016","unstructured":"Yadav A, Gupta A, Rastogi N, Agrawal S, Kumar A, Kumar V, et al. Association of cancer stem cell markers genetic variants with gallbladder cancer susceptibility, prognosis, and survival. Tumour Biol. 2016;37(2):1835\u201344.","journal-title":"Tumour Biol"},{"key":"3799_CR33","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.2147\/CMAR.S175681","volume":"10","author":"Y He","year":"2018","unstructured":"He Y, Xue C, Yu Y, Chen J, Chen X, Ren F, et al. CD44 is overexpressed and correlated with tumor progression in gallbladder cancer. Cancer Manag Res. 2018;10:3857\u201365.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"3799_CR34","doi-asserted-by":"publisher","first-page":"165424","DOI":"10.1016\/j.bbadis.2019.02.019","volume":"1866","author":"S Prasad","year":"2020","unstructured":"Prasad S, Ramachandran S, Gupta N, Kaushik I, Srivastava SK. Cancer cells stemness: A doorstep to targeted therapy. Biochim Biophys Acta Mol Basis Dis. 2020;1866(4):165424.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"21","key":"3799_CR35","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.1111\/febs.13023","volume":"281","author":"S Colak","year":"2014","unstructured":"Colak S, Medema JP. Cancer stem cells\u2013important players in tumor therapy resistance. FEBS J. 2014;281(21):4779\u201391.","journal-title":"FEBS J"},{"issue":"1","key":"3799_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13046-018-0864-6","volume":"37","author":"J Zhang","year":"2018","unstructured":"Zhang J, Cai H, Sun L, Zhan P, Chen M, Zhang F, et al. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt\/\u03b2-catenin pathway and predicts poor survival of glioma patients. J Exp Clin Cancer Res. 2018;37(1):225.","journal-title":"J Exp Clin Cancer Res"},{"key":"3799_CR37","doi-asserted-by":"publisher","first-page":"121171","DOI":"10.1016\/j.lfs.2022.121171","volume":"311","author":"N Unver","year":"2022","unstructured":"Unver N, Tavukcuoglu E, Esendagli G. Tailored modulation of stemness and drug resistance marker characteristics in K-Ras mutant lung cancer cells via PD-L1 gene suppression. Life Sci. 2022;311:121171. Pt B).","journal-title":"Life Sci"},{"key":"3799_CR38","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.3389\/fmicb.2019.02363","volume":"10","author":"Q Dong","year":"2019","unstructured":"Dong Q, Li Y, Liu G, Zhang Z, Zhou H, Yang H. High oxygen treatments enhance the contents of phenolic compound and Ganoderic acid, and the antioxidant and DNA damage protective activities of ganoderma Lingzhi fruiting body. Front Microbiol. 2019;10:2363.","journal-title":"Front Microbiol"},{"issue":"1","key":"3799_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-022-04154-6","volume":"6","author":"YN Liu","year":"2023","unstructured":"Liu YN, Wu FY, Tian RY, Shi YX, Xu ZQ, Liu JY, et al. The bHLH-zip transcription factor SREBP regulates triterpenoid and lipid metabolisms in the medicinal fungus ganoderma Lingzhi. Commun Biol. 2023;6(1):1.","journal-title":"Commun Biol"},{"issue":"5","key":"3799_CR40","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S1470-2045(24)00082-2","volume":"25","author":"HA Burris","year":"2024","unstructured":"Burris HA 3rd, Okusaka T, Vogel A, Lee MA, Takahashi H, Breder V, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2024;25(5):626\u201335.","journal-title":"Lancet Oncol"},{"issue":"1","key":"3799_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11011-024-01429-1","volume":"40","author":"N Shao","year":"2024","unstructured":"Shao N, Lu Q, Ouyang Z, Yang P, Wei T, Wang J, et al. Ganoderic acid a alleviates Abeta(25\u201335)-induced HT22 cell apoptosis through the ERK\/MAPK pathway: a system Pharmacology and in vitro experimental validation. Metab Brain Dis. 2024;40(1):51.","journal-title":"Metab Brain Dis"},{"issue":"4","key":"3799_CR42","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s40617-020-00547-3","volume":"14","author":"SG Walker","year":"2021","unstructured":"Walker SG, Carr JE. Generality of findings from Single-Case designs: it\u2019s not all about the N. Behav Anal Pract. 2021;14(4):991\u20135.","journal-title":"Behav Anal Pract"},{"key":"3799_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/B978-0-12-380888-2.00003-0","volume":"108","author":"J Smith","year":"2010","unstructured":"Smith J, Tho LM, Xu N, Gillespie DA. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res. 2010;108:73\u2013112.","journal-title":"Adv Cancer Res"},{"issue":"6","key":"3799_CR44","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/jmcb\/mju045","volume":"6","author":"L Zannini","year":"2014","unstructured":"Zannini L, Delia D, Buscemi G. CHK2 kinase in the DNA damage response and beyond. J Mol Cell Biol. 2014;6(6):442\u201357.","journal-title":"J Mol Cell Biol"},{"key":"3799_CR45","doi-asserted-by":"crossref","unstructured":"Jia Y, Li Y, Shang H, Luo Y, Tian Y, Ganoderic Acid A. and Its amide derivatives as potential Anti-Cancer agents by regulating the p53-MDM2 pathway: synthesis and biological evaluation. Molecules. 2023;28(5).","DOI":"10.3390\/molecules28052374"},{"issue":"2","key":"3799_CR46","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1021\/acs.jafc.4c07635","volume":"73","author":"L Zhang","year":"2025","unstructured":"Zhang L, Wang K, Huang L, Deng B, Chen C, Zhao K, et al. Ganoderic acid A alleviates severe acute pancreatitis by modulating gut homeostasis and inhibiting TLR4-NLRP3 signaling. J Agric Food Chem. 2025;73(2):1563\u201379.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"3799_CR47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13045-019-0754-1","volume":"12","author":"H Hua","year":"2019","unstructured":"Hua H, Kong Q, Zhang H, Wang J, Luo T, Jiang Y. Targeting mTOR for cancer therapy. J Hematol Oncol. 2019;12(1):71.","journal-title":"J Hematol Oncol"},{"key":"3799_CR48","doi-asserted-by":"crossref","unstructured":"Yang M, Lu Y, Piao W, Jin H. The translational regulation in mTOR pathway. Biomolecules. 2022;12(6).","DOI":"10.3390\/biom12060802"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03799-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03799-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03799-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T17:04:07Z","timestamp":1745255047000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03799-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3799"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03799-x","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}